Training in normobaric hypoxia and its effects on acute mountain sickness after rapid ascent to 4559 m

In a randomized, placebo-controlled, double-blind study, we tested a 4-week program in normobaric hypoxia that is commercially offered for the prevention of acute mountain sickness (AMS).

Saved in:

Bibliographic Details
Main Authors:	Schommer, Kai (Author) , Wiesegart, Neele Ruth (Author) , Menold, Elmar (Author) , Haas, Ute (Author) , Lahr, Katrin (Author) , Buhl, Hermann (Author) , Bärtsch, Peter (Author) , Dehnert, Christoph (Author)
Format:	Article (Journal)
Language:	English
Published:	31 Mar 2010
In:	High altitude medicine & biology Year: 2010, Volume: 11, Issue: 1, Pages: 19-25
ISSN:	1557-8682
DOI:	10.1089/ham.2009.1019
Online Access:	Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1089/ham.2009.1019 Verlag, lizenzpflichtig, Volltext: https://www.liebertpub.com/doi/10.1089/ham.2009.1019
Author Notes:	Kai Schommer, Neele Wiesegart, Elmar Menold, Ute Haas, Katrin Lahr, Hermann Buhl, Peter Bärtsch, Christoph Dehnert

Description
Summary:	In a randomized, placebo-controlled, double-blind study, we tested a 4-week program in normobaric hypoxia that is commercially offered for the prevention of acute mountain sickness (AMS).
Item Description:	Gesehen am 29.06.2023
Physical Description:	Online Resource
ISSN:	1557-8682
DOI:	10.1089/ham.2009.1019